Second J&J vaccine fatality recorded
The SA Health Products Regulatory Authority (SAHPRA) confirmed that another person died from Guillain-Barré syndrome (GBS) after receiving the Johnson & Johnson (J&J) Covid-19 vaccine. SAPHRA confirmed the first GBS death early last month.
In a statement released Monday, SAHPRA said the National Immunisation Safety Expert Committee (NISEC) did a causality assessment of the reported case using the World Health Organization’s (WHO) methodology. The death was classified as a vaccine product-related event.
GBS is a very rare but potentially severe neurological adverse event associated with administering various vaccines and other medicines. Some bacterial or viral infections, including SARS-CoV-2 can also trigger it, said SAHPRA.
Investigations ongoing
“Investigations and causality assessment of all reported severe AEFI with the COVID-19 Vaccine Janssen and other COVID-19 vaccines are ongoing. The outcomes of these investigations and causality assessments will be shared with the public as soon as they are completed.”
Previous investigations by regulatory authorities concluded the J&J vaccine might increase the risk of GBS. The syndrome is a rare adverse event in the professional information for COVID-19 Janssen vaccine.
Based on the currently available evidence, SAHPRA has determined that the benefits of COVID- 19 vaccination far outweigh the very low risk of severe adverse events, including GBS. The public is strongly advised not to delay getting vaccinated against COVID-19 if eligible under the national vaccination programme. The authority also urged the public to report any suspected adverse events following the use of all medicines and vaccines.
So far, 37,544,120 vaccines have been administered in South Africa. A total number of 9,210,329 J&J vaccine doses have been administered. The bulk of these was given in Gauteng. – Health-e News
*Reporting can be done at a health facility; by downloading the Med Safety App (https://medsafety.sahpra.org.za/), which is available for Android and iOS phones, or by calling the COVID-19 hotline at 0800 029 999.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Second J&J vaccine fatality recorded
by healthe, Health-e News
September 12, 2022